Sun Pharma to consider internal restructuring of business

Drug major Sun Pharma said its board will meet later this week to consider internal restructuring of the business and to announce first quarter results.

The Mumbai-headquartered firm said in a filing to the BSE that its board on 10 August "would consider the internal restructuring of the business of the company with effect from 31 March, 2012".

.Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade. Reuters

The board will also announce the financial results of the company for the first quarter ended 30 June, 2012. The board would also consider declaration of the interim dividend of Rs 4.25 per share of Re 1 each on equity shares of the company for the year ended March 31, 2012, the filing said.

Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade, up 1.55 percent from its previous close.

PTI


Updated Date: Dec 20, 2014 10:58 AM

Also Watch

Watch: Firstpost test rides the new Thunderbird 500X in Goa and walks you through the Royal Enfield Garage Cafe
  • Tuesday, April 17, 2018 Varun Dhawan on Shoojit Sircar's October, 5-star reviews and working with Anushka Sharma in Sui Dhaaga
  • Saturday, April 14, 2018 Ambedkar Jayanti: Re-visiting Babasaheb's ideals exposes fake Dalit politics of Rahul Gandhi and Congress
  • Monday, April 9, 2018 48 hours with Huawei P20 Pro: Triple camera offering is set to redefine smartphone imaging
  • Monday, April 16, 2018 Rajyavardhan Singh Rathore interview: Sports can't be anyone's fiefdom, we need an ecosystem to nurture raw talent